Guilford Pharmaceuticals, Inc. SBIR Phase I Award,
A SBIR Phase I contract was awarded to Guilford Pharmaceuticals, Inc. for $140,170.0 USD from the U.S. Department of Health & Human Services.
All edits
Edits on 11 May, 2021
Golden AI
Edits made to:
Infobox (+1/-1 properties)
Infobox
Edits on 13 Mar, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
Guilford Pharmaceuticals, Inc. SBIR Phase I Award,
Infobox
Is a
Recipient
Award Type
SBIR
Award Identifier
1R43CA103568-01
Phase
Phase I
Amount (USD)
140,170
Find more entities like Guilford Pharmaceuticals, Inc. SBIR Phase I Award,
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.